- Lobbying
- PAUL AND D AND STONE
Lobbying Arrangements Results for 'Paul D Stone'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally, and/ Celgene specifically |
Celgene Corporation
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Merck specifically |
Merck & Co., Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biotechnology industry |
Sanofi US Services, Inc.
|
BGR Government Affairs | |||
Details Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues |
Eli Lilly & Co, Inc.
|
BGR Government Affairs | |||
Details Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically |
Alkermes, Inc.
Biopharmaceutical company |
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Zogenix specifically. |
Zogenix, Inc.
|
BGR Government Affairs | |||
Details Legislation and regulations affecting the long-term care pharmacy industry |
Senior Care Pharmacy Coalition
|
BGR Government Affairs | |||
Details Advise and advocate on clients behalf regarding ongoing public policy concerns impacting the innovative biopharmaceutical industry in Congress and throughout the Administration. |
Pharmaceutical Research and Manufacturers of America
|
BGR Government Affairs | |||
Details Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid and FDA |
GlaxoSmithKline, INC
|
BGR Government Affairs | |||
Details Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Ca... |
Amgen Inc.
|
BGR Government Affairs | |||
Details FY 24 Appropriations THUD, provisions related to agency funding and material neutrality policies, FAA research, ROCKS Act implementation FSSG, provisions related to agency rulemaking LHHS, provisi... |
NATIONAL STONE, SAND AND GRAVEL ASSOCIATION
|
in-house lobbying | |||
Details Provide guidance and counsel with regard to federal medical device policy and regulatory issues and reimbursement issues within Medicare program, including IPPS Regulation, and FDA regulatory policy. |
Abiomed Inc.
|
BGR Government Affairs | |||
Details Aerospace to include space and satellite programs. Acquisition policy. Science programs. Spectrum - to include 5G. Data rights issues. FY24 NASA Authorization legislation. FY24 CJS Appropriations. ... |
BOEING COMPANY
|
in-house lobbying | |||
Details Monitor and engage on federal legislation and administrative action related to energy provisions related to climate, carbon, power, fuel and feedstocks. H.R. 1, Lower Energy Costs Act. H.R. 209, P... |
The Dow Chemical Company, dba Dow
|
in-house lobbying |